PQ 411
411. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 535 of 20 September 2017, if his attention has been drawn to the impact that the changes of the prescribing of Lidocaine has had on persons with chronic neuropathic pain; if the HSE medicines management programme has investigated the impact that changes to the prescription of pain medication has on persons with chronic neuropathic pain; and if he will make a statement on the matter. [42219/17]
Introduced
10 October 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
10 October 2017
Summary
411. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 535 of 20 September 2017, if his attention has been drawn to the impact that the changes of the prescribing of Lidocaine has had on persons with chronic neuropathic pain; if the HSE medicines management programme has investigated the impact that changes to the prescription of pain medication has on persons with chronic neuropathic pain; and if he will make a statement on the matter. [42219/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medical Card Drugs Availability
Medical Card Drugs Availability
xml · EN · 10 October 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-10-10/411/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-10-10/pq_411